• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在一名患有注意力缺陷/多动障碍合并双相情感障碍和抽动秽语综合征的10岁儿童中同时使用托莫西汀和OROS-哌甲酯。

Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.

作者信息

Jaworowski Sol, Benarroch Fortu, Gross-Tsur Varda

机构信息

Department of Liaison Consultation Psychiatry, Shaare Zedek Medical Centre, Jerusalem, Israel 91031.

出版信息

J Child Adolesc Psychopharmacol. 2006 Jun;16(3):365-70. doi: 10.1089/cap.2006.16.365.

DOI:10.1089/cap.2006.16.365
PMID:16768644
Abstract

Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS). The child received valproic acid, clonidine, and ziprasidone concurrently. Because possible side effects of pharmacological treatment for one diagnosis may exacerbate a comorbid condition, contingent management strategies, when using polypharmacy, are mandated.

摘要

托莫西汀和奥氮平控释片成功地联合用于一名患有注意力缺陷多动障碍（ADHD）并伴有双相情感障碍和抽动秽语综合征（TS）的10岁男孩。该患儿同时接受丙戊酸、可乐定和齐拉西酮治疗。由于针对一种病症进行药物治疗可能产生的副作用会加重共病状况，因此在联合用药时必须采用应急管理策略。

相似文献

1
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.在一名患有注意力缺陷/多动障碍合并双相情感障碍和抽动秽语综合征的10岁儿童中同时使用托莫西汀和OROS-哌甲酯。
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):365-70. doi: 10.1089/cap.2006.16.365.
2
Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.注意缺陷多动障碍、抽动症与妥瑞氏综合征：关系及治疗意义。一篇评论。
Eur Child Adolesc Psychiatry. 2006 Feb;15(1):1-11. doi: 10.1007/s00787-006-0505-z.
3
Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.从阿托莫西汀转换为奥洛他定（®）哌甲酯对 ADHD 儿童和青少年有效。
Expert Rev Neurother. 2011 Apr;11(4):499-508. doi: 10.1586/ern.11.18.
4
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
5
Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.接受替代药物疗法治疗的注意力缺陷/多动障碍成人的医疗费用。
J Manag Care Pharm. 2007 Sep;13(7):561-9. doi: 10.18553/jmcp.2007.13.7.561.
6
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.荟萃分析：合并抽动障碍的儿童注意力缺陷/多动障碍的治疗
J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-893. doi: 10.1097/CHI.0b013e3181b26e9f.
7
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.托莫西汀治疗合并抽动秽语综合征儿童的注意力缺陷多动障碍
J Atten Disord. 2008 Jan;11(4):470-81. doi: 10.1177/1087054707306109. Epub 2007 Oct 12.
8
Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.妥瑞氏症候群与共病注意力不足过动症：现行药物治疗选择。
Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7.
9
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.注意缺陷多动障碍儿童及青少年从哌甲酯或苯丙胺转换为托莫西汀的初步耐受性和疗效研究
Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017.
10
Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?托莫西汀能否提高哌甲酯治疗注意力缺陷多动障碍的疗效？
Psychiatr Danub. 2009 Sep;21(3):330.

引用本文的文献

1
ADHD-juvenile bipolar disorder: mimics and chameleons!
World J Pediatr. 2018 Dec;14(6):525-527. doi: 10.1007/s12519-018-0124-z. Epub 2018 Feb 14.
2
Off-label use of atomoxetine in adults: is it safe?成人使用非专利药托莫西汀：安全吗？
Ment Illn. 2012 Sep 24;4(2):e19. doi: 10.4081/mi.2012.e19. eCollection 2012 Jul 26.
3
A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.对用于治疗注意力缺陷多动障碍的兴奋剂与托莫西汀联合疗法的系统评价，包括患者特征、治疗策略、有效性和耐受性。
J Child Adolesc Psychopharmacol. 2013 Apr;23(3):179-93. doi: 10.1089/cap.2012.0093. Epub 2013 Apr 6.
4
Atomoxetine and stimulant medications in children and adolescents with persistent symptoms of attention deficit hyperactivity disorder despite monotherapy.尽管进行了单一疗法，但患有持续性注意力缺陷多动障碍症状的儿童和青少年使用托莫西汀和兴奋剂药物的情况。
Can Pharm J (Ott). 2012 Sep;145(5):226-230.e1. doi: 10.3821/145.5.cpj226.
5
Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.青少年注意缺陷多动障碍遗传模型中策略集转换任务的表现：哌甲酯与托莫西汀治疗。
Behav Brain Res. 2013 May 1;244:38-47. doi: 10.1016/j.bbr.2013.01.027. Epub 2013 Jan 31.
6
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.1996-2007 年，基于诊间的儿童和青少年精神科药物联用的全国趋势。
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.
7
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.托莫西汀在注意力缺陷多动障碍合并其他病症患者中的应用。
CNS Drugs. 2009 Sep;23(9):739-53. doi: 10.2165/11314350-000000000-00000.